SSEA-3 as a novel amplifying cancer cell surface marker in colorectal cancers

International Journal of Oncology

Volumn 42, Issue 1, 2013, Pages 161-167

  Suzuki, Yozo ^a   Haraguchi, Naotsugu ^a   Takahashi, Hidekazu ^a   Uemura, Mamoru ^a   Nishimura, Junichi ^a   Hata, Taishi ^a   Takemasa, Ichiro ^a   Mizushima, Tsunekazu ^a   Ishii, Hideshi ^a   Doki, Yuichiro ^a   Mori, Masaki ^a   Yamamoto, Hirofumi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cancer stem cell; Cell proliferation; Colorectal cancer; Stage specific embryonic antigen 3

Indexed keywords

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; ALCOHOL DEHYDROGENASE; CD24 ANTIGEN; CELL SURFACE MARKER; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; DIPEPTIDYL PEPTIDASE IV; ENDOGLIN; HERMES ANTIGEN; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; STAGE SPECIFIC EMBRYO ANTIGEN 3; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2;

ANTIGEN EXPRESSION; ARTICLE; CANCER CELL; CARCINOGENESIS; CARCINOGENICITY; CELL CYCLE; CELL EXPANSION; CELL PROLIFERATION; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; IN VIVO STUDY; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; STROMA CELL;

ADENOCARCINOMA; ANIMALS; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; BLOTTING, WESTERN; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; COLORECTAL NEOPLASMS; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASM STAGING; NEOPLASTIC STEM CELLS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STAGE-SPECIFIC EMBRYONIC ANTIGENS; STROMAL CELLS; TUMOR MARKERS, BIOLOGICAL;

EID: 84873646595     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1713     Document Type: Article

References (29)

1. Ben-Porath I, Thomson MW, Carey VJ, et al: An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 40: 499-507, 2008. (Pubitemid 351601215)
2. Levina V, Marrangoni AM, DeMarco R, Gorelik E and Lokshin AE: Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties. PLoS One 3: E3077, 2008.
3. Rajasekhar VK, Studer L, Gerald W, Socci ND and Scher HI: Tumour-initiating stem-like cells in human prostate cancer exhibit increased NF-kappaB signalling. Nat Commun 2: 162, 2011.
4. Wright AJ and Andrews PW: Surface marker antigens in the characterization of human embryonic stem cells. Stem Cell Res 3: 3-11, 2009.
5. Solter D and Knowles BB: Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1). Proc Natl Acad Sci USA 75: 5565-5569, 1978. (Pubitemid 9084529)
6. Shevinsky LH, Knowles BB, Damjanov I and Solter D: Monoclonal antibody to murine embryos defines a stage-specific embryonic antigen expressed on mouse embryos and human teratocarcinoma cells. Cell 30: 697-705, 1982. (Pubitemid 13204659)
7. Kannagi R, Cochran NA, Ishigami F, et al: Stage-specific embryonic antigens (SSEA-3 and -4) are epitopes of a unique globo-series ganglioside isolated from human teratocarcinoma cells. EMBO J 2: 2355-2361, 1983.
8. Solter D, Shevinsky L, Knowles BB and Strickland S: The induction of antigenic changes in a teratocarcinoma stem cell line (F9) by retinoic acid. Dev Biol 70: 515-521, 1979. (Pubitemid 10223315)
9. Evans MJ and Kaufman MH: Establishment in culture of pluripotential cells from mouse embryos. Nature 292: 154-156, 1981. (Pubitemid 11050741)
10. Takahashi K and Yamanaka S: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676, 2006. (Pubitemid 44233629)
11. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al: Embryonic stem cell lines derived from human blastocysts. Science 282: 1145-1147, 1998. (Pubitemid 28516247)
12. Takahashi K, Tanabe K, Ohnuki M, et al: Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861-872, 2007. (Pubitemid 350138099)
13. Kuroda Y, Kitada M, Wakao S, et al: Unique multipotent cells in adult human mesenchymal cell populations. Proc Natl Acad Sci USA 107: 8639-8643, 2010.
14. Kannagi R: Carbohydrate-mediated cell adhesion involved in hematogenous metastasis of cancer. Glycoconj J 14: 577-584, 1997. (Pubitemid 27353201)
15. Son MJ, Woolard K, Nam DH, Lee J and Fine HA: SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma. Cell Stem Cell 4: 440-452, 2009.
16. Ye F, Li Y, Hu Y, Zhou C and Chen H: Stage-specific embryonic antigen 4 expression in epithelial ovarian carcinoma. Int J Gynecol Cancer 20: 958-964, 2010.
17. Chang WW, Lee CH, Lee P, et al: Expression of Globo H and SSEA3 in breast cancer stem cells and the involvement of fucosyl transferases 1 and 2 in Globo H synthesis. Proc Natl Acad Sci USA 105: 11667-11672, 2008.
18. Yamamoto H, Kondo M, Nakamori S, et al: JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis1. Gastroenterology 125: 556-571, 2003. (Pubitemid 36929437)
19. Bello LJ: Studies on gene activity in synchronized culture of mammalian cells. Biochim Biophys Acta 179: 204-213, 1969.
20. Wilker EW, van Vugt MA, Artim SA, et al: 14-3-3sigma controls mitotic translation to facilitate cytokinesis. Nature 446: 329-332, 2007. (Pubitemid 46426148)
21. Ware JL and DeLong ER: Influence of tumour size on human prostate tumour metastasis in athymic nude mice. Br J Cancer 51: 419-423, 1985. (Pubitemid 15127269)
22. Todaro M, Francipane MG, Medema JP and Stassi G: Colon cancer stem cells: promise of targeted therapy. Gastroenterology 138: 2151-2162, 2010.
23. Wakao S, Kitada M, Kuroda Y, et al: Multilineage-differentiating stress-enduring (Muse) cells are a primary source of induced pluripotent stem cells in human fibroblasts. Proc Natl Acad Sci USA 108: 9875-9880, 2011.
24. Stewart MH, Bosse M, Chadwick K, Menendez P, Bendall SC and Bhatia M: Clonal isolation of hESCs reveals heterogeneity within the pluripotent stem cell compartment. Nat Methods 3: 807-815, 2006. (Pubitemid 44445828)
25. Yeung TM, Gandhi SC, Wilding JL, Muschel R and Bodmer WF: Cancer stem cells from colorectal cancer-derived cell lines. Proc Natl Acad Sci USA 107: 3722-3727, 2010.
26. Dieter SM, Ball CR, Hoffmann CM, et al: Distinct types of tumor-initiating cells form human colon cancer tumors and metastases. Cell Stem Cell 9: 357-365, 2011.
27. Wander SA, Zhao D and Slingerland JM: p27: a barometer of signaling deregulation and potential predictor of response to targeted therapies. Clin Cancer Res 17: 12-18, 2011.
28. Baldassarre G, Barone MV, Belletti B, et al: Key role of the cyclin-dependent kinase inhibitor p27kip1 for embryonal carcinoma cell survival and differentiation. Oncogene 18: 6241-6251, 1999.
29. Niculescu AB III, Chen X, Smeets M, Hengst L, Prives C and Reed SI: Effects of p21(Cip1/Waf1) at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication. Mol Cell Biol 18: 629-643, 1998. (Pubitemid 28021073)